S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:MASS

908 Devices Stock Forecast, Price & News

$23.17
-1.15 (-4.73%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$22.83
$24.59
50-Day Range
$23.17
$38.77
52-Week Range
$22.21
$79.60
Volume
465,243 shs
Average Volume
373,295 shs
Market Capitalization
$646.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive MASS News and Ratings via Email

Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter.


908 Devices logo

About 908 Devices

908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Headlines

908 Devices Inc. (NASDAQ:MASS) Short Interest Update
November 30, 2021 |  americanbankingnews.com
908 Devices (NASDAQ:MASS) Sets New 1-Year Low at $22.30
November 23, 2021 |  americanbankingnews.com
Oversold Conditions For 908 Devices
November 22, 2021 |  nasdaq.com
908 Devices Inc. (NASDAQ:MASS) VP John Kenneweg Sells 10,000 Shares
November 18, 2021 |  americanbankingnews.com
908 Devices (NASDAQ:MASS) Stock Price Down 8.4%
November 18, 2021 |  americanbankingnews.com
908 Devices (NASDAQ:MASS) Sets New 12-Month Low at $28.91
November 17, 2021 |  americanbankingnews.com
908 Devices (NASDAQ:MASS) Sees Strong Trading Volume
November 11, 2021 |  americanbankingnews.com
908 Devices Announces Pricing of Public Offering
November 10, 2021 |  finance.yahoo.com
908 Devices (NASDAQ:MASS) Shares Gap Down to $38.77
November 9, 2021 |  americanbankingnews.com
908 Devices Announces Launch of Public Offering
November 8, 2021 |  finance.yahoo.com
908 Devices earnings: here's what Wall Street expects
November 5, 2021 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Measuring & controlling devices, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MASS
Fax
N/A
Employees
101
Year Founded
N/A

Sales & Book Value

Annual Sales
$26.89 million
Book Value
$4.40 per share

Profitability

Net Income
$-12.82 million
Pretax Margin
-90.18%

Debt

Price-To-Earnings

Miscellaneous

Free Float
13,643,000
Market Cap
$646.44 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/03/2021
Today
12/04/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
3/29/2022

MarketRank

Overall MarketRank

2.34 out of 5 stars

Medical Sector

246th out of 1,390 stocks

Measuring & Controlling Devices, Not Elsewhere Classified Industry

3rd out of 17 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -












908 Devices (NASDAQ:MASS) Frequently Asked Questions

Is 908 Devices a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" 908 Devices stock.
View analyst ratings for 908 Devices
or view top-rated stocks.

Are investors shorting 908 Devices?

908 Devices saw a drop in short interest in November. As of November 15th, there was short interest totaling 1,310,000 shares, a drop of 40.2% from the October 31st total of 2,190,000 shares. Based on an average daily volume of 263,900 shares, the short-interest ratio is presently 5.0 days. Currently, 11.1% of the company's shares are short sold.
View 908 Devices' Short Interest
.

When is 908 Devices' next earnings date?

908 Devices is scheduled to release its next quarterly earnings announcement on Tuesday, March 29th 2022.
View our earnings forecast for 908 Devices
.

How were 908 Devices' earnings last quarter?

908 Devices Inc. (NASDAQ:MASS) posted its quarterly earnings results on Wednesday, November, 3rd. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.15) by $0.04. The company had revenue of $12.50 million for the quarter, compared to analyst estimates of $12.03 million. 908 Devices had a negative net margin of 90.18% and a negative trailing twelve-month return on equity of 17.50%. The business's revenue was up 104.9% on a year-over-year basis.
View 908 Devices' earnings history
.

What guidance has 908 Devices issued on next quarter's earnings?

908 Devices updated its FY 2021 earnings guidance on Thursday, November, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $41 million-$43 million, compared to the consensus revenue estimate of $41.41 million.

What price target have analysts set for MASS?

4 brokerages have issued 1-year price objectives for 908 Devices' stock. Their forecasts range from $65.00 to $74.00. On average, they anticipate 908 Devices' stock price to reach $68.00 in the next year. This suggests a possible upside of 193.5% from the stock's current price.
View analysts' price targets for 908 Devices
or view top-rated stocks among Wall Street analysts.

Who are 908 Devices' key executives?

908 Devices' management team includes the following people:
  • Dr. Kevin J. Knopp Ph.D., Co-Founder, CEO, Pres & Director (Age 48, Pay $371.75k)
  • Dr. John Michael Ramsey, Science Founder & Director (Age 68, Pay $61.44k)
  • Mr. Michael S. Turner Esq., J.D., VP, Sec. & Gen. Counsel (Age 54, Pay $97.84k)
  • Dr. Christopher David Brown Ph.D., Co-Founder, CTO, VP of R&D and Sec. (Age 46)
  • Mr. Steve Araiza, Co-founder & Software Architect
  • Mr. Andrew Bartfay, Co-Founder & Director of Hardware Devel.
  • Mr. Michael Jobin, Co-Founder & Director of Product Devel.
  • Dr. Scott Miller Ph.D., Co-founder & Director of MS Engineering
  • Mr. Joseph H. Griffith IV, CFO & Treasurer (Age 46) (LinkedIn Profile)
  • Ms. Maura Fitzpatrick, VP of Product Management & Marketing (Age 51)

When did 908 Devices IPO?

(MASS) raised $101 million in an IPO on Friday, December 18th 2020. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO.

What is 908 Devices' stock symbol?

908 Devices trades on the NASDAQ under the ticker symbol "MASS."

Who are 908 Devices' major shareholders?

908 Devices' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (11.92%), Granahan Investment Management Inc. MA (2.26%), Millennium Management LLC (2.12%), Sumitomo Mitsui Trust Holdings Inc. (2.07%), Nikko Asset Management Americas Inc. (2.05%) and Sands Capital Ventures LLC (1.18%). Company insiders that own 908 Devices stock include Christopher D Brown, Christopher D Brown, E Kevin Hrusovsky, John Kenneweg, Joseph H Iv Griffith, Kevin J Knopp, Michael S Turner, Nicolas Barthelemy, Trent A Basarsky, Trent A Basarsky and Venture Fund Vii LP Arch.
View institutional ownership trends for 908 Devices
.

Which institutional investors are selling 908 Devices stock?

MASS stock was sold by a variety of institutional investors in the last quarter, including Primecap Management Co. CA, Rafferty Asset Management LLC, and UBS Group AG. Company insiders that have sold 908 Devices company stock in the last year include Christopher D Brown, John Kenneweg, Joseph H Iv Griffith, Kevin J Knopp, Nicolas Barthelemy, and Trent A Basarsky.
View insider buying and selling activity for 908 Devices
or view top insider-selling stocks.

Which institutional investors are buying 908 Devices stock?

MASS stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Millennium Management LLC, Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Sands Capital Ventures LLC, TimesSquare Capital Management LLC, Thrivent Financial for Lutherans, and Emerald Advisers LLC. Company insiders that have bought 908 Devices stock in the last two years include E Kevin Hrusovsky, Michael S Turner, and Venture Fund Vii LP Arch.
View insider buying and selling activity for 908 Devices
or or view top insider-buying stocks.

How do I buy shares of 908 Devices?

Shares of MASS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 908 Devices' stock price today?

One share of MASS stock can currently be purchased for approximately $23.17.

How much money does 908 Devices make?

908 Devices has a market capitalization of $646.44 million and generates $26.89 million in revenue each year. The company earns $-12.82 million in net income (profit) each year or ($2.16) on an earnings per share basis.

How many employees does 908 Devices have?

908 Devices employs 101 workers across the globe.

What is 908 Devices' official website?

The official website for 908 Devices is www.908devices.com.

How can I contact 908 Devices?

The company can be reached via phone at 857-254-1500.


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.